Silence Therapeutics plc Number Of Share Options Granted In Share-based Payment Arrangement
Silence Therapeutics plc (SLN) reported Number Of Share Options Granted In Share-based Payment Arrangement of 7.70 million shares for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2024-03-13
shares
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month | Number Of Share Options Granted In Share-based Payment Arrangement 12 month as first filed |
|---|---|---|
| 2023-12-31 | 7.70M shares 20-F · filed 2024-03-13 | |
| 2022-12-31 | 5.82M shares 20-F · filed 2024-03-13 | |
| 2021-12-31 | 2.26M shares 20-F · filed 2024-03-13 | |
| 2020-12-31 | 3.18M shares 20-F · filed 2023-03-15 | 3.17M shares 20-F/A · filed 2021-04-29 |
| 2019-12-31 | 4.72M shares 20-F · filed 2022-03-17 | |
| 2018-12-31 | 1.04M shares 20-F/A · filed 2021-04-29 |
AmericanDepositarySh
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|
| 2023-12-31 | 2.57M AmericanDepositarySh 20-F · filed 2024-03-13 |
| 2022-12-31 | 1.94M AmericanDepositarySh 20-F · filed 2024-03-13 |